Literature DB >> 27628916

Hemochromatosis: a model of metal-related human toxicosis.

Pierre Brissot1,2,3, Thibault Cavey4,5, Martine Ropert4,5, François Gaboriau5, Olivier Loréal5.   

Abstract

Many environmental agents, such as excessive alcohol intake, xenobiotics, and virus, are able to damage the human body, targeting especially the liver. Metal excess may also assault the liver. Thus, chronic iron overload may cause, especially when associated with cofactors, diffuse organ damage that is a source of significant morbidity and mortality. Iron excess can be either of acquired (mostly transfusional) or of genetic origin. Hemochromatosis is the archetype of genetic iron overload diseases and represents a serious health problem. A better understanding of iron metabolism has deeply modified the hemochromatosis field which today benefits from much more efficient diagnostic and therapeutic approaches.

Entities:  

Keywords:  Ferroportin; Hepcidin; Iron chelation; Iron overload; Labile plasma iron; Lipid peroxidation; Liver fibrosis; Non-transferrin bound iron; Reactive oxygen species; Tumorogenesis; Venesection

Mesh:

Substances:

Year:  2016        PMID: 27628916     DOI: 10.1007/s11356-016-7576-2

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  62 in total

1.  Dietary iron intake and serum ferritin concentration in 213 patients homozygous for the HFEC282Y hemochromatosis mutation.

Authors:  Victor R Gordeuk; Laura Lovato; James Barton; Mara Vitolins; Gordon McLaren; Ronald Acton; Christine McLaren; Emily Harris; Mark Speechley; John H Eckfeldt; Sharmin Diaz; Phyliss Sholinsky; Paul Adams
Journal:  Can J Gastroenterol       Date:  2012-06       Impact factor: 3.522

2.  Kinetic evaluation of free malondialdehyde and enzyme leakage as indices of iron damage in rat hepatocyte cultures. Involvement of free radicals.

Authors:  I Morel; G Lescoat; J Cillard; N Pasdeloup; P Brissot; P Cillard
Journal:  Biochem Pharmacol       Date:  1990-06-01       Impact factor: 5.858

3.  Antiproliferative and apoptotic effects in rat and human hepatoma cell cultures of the orally active iron chelator ICL670 compared to CP20: a possible relationship with polyamine metabolism.

Authors:  G Lescoat; K Chantrel-Groussard; N Pasdeloup; H Nick; P Brissot; F Gaboriau
Journal:  Cell Prolif       Date:  2007-10       Impact factor: 6.831

4.  Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis.

Authors:  Felix Stickel; Stephan Buch; Heinz Zoller; Rolf Hultcrantz; Sabina Gallati; Christoph Österreicher; Armin Finkenstedt; Andreas Stadlmayr; Elmar Aigner; Enijad Sahinbegovic; Christoph Sarrazin; Clemens Schafmayer; Felix Braun; Wiebke Erhart; Michael Nothnagel; Markus M Lerch; Julia Mayerle; Henry Völzke; André Schaller; Wolfgang Kratzer; Bernhard O Boehm; Bence Sipos; Mauro D'Amato; Leif Torkvist; Per Stal; Alexander Arlt; Andre Franke; Thomas Becker; Michael Krawczak; Jochen Zwerina; Thomas Berg; Holger Hinrichsen; Elisabeth Krones; Christian Dejaco; Michael Strasser; Christian Datz; Jochen Hampe
Journal:  Hum Mol Genet       Date:  2014-02-20       Impact factor: 6.150

5.  A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis.

Authors:  Marie-Laure Island; Anne-Marie Jouanolle; Annick Mosser; Yves Deugnier; Véronique David; Pierre Brissot; Olivier Loréal
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

6.  Pathology of dietary carbonyl iron overload in rats.

Authors:  C H Park; B R Bacon; G M Brittenham; A S Tavill
Journal:  Lab Invest       Date:  1987-11       Impact factor: 5.662

Review 7.  Iron deficiency anemia in celiac disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

8.  In overweight and obese women, dietary iron absorption is reduced and the enhancement of iron absorption by ascorbic acid is one-half that in normal-weight women.

Authors:  Ana C Cepeda-Lopez; Alida Melse-Boonstra; Michael B Zimmermann; Isabelle Herter-Aeberli
Journal:  Am J Clin Nutr       Date:  2015-11-11       Impact factor: 7.045

9.  Labile plasma iron in iron overload: redox activity and susceptibility to chelation.

Authors:  Breno P Esposito; William Breuer; Pornpan Sirankapracha; Pensri Pootrakul; Chaim Hershko; Z Ioav Cabantchik
Journal:  Blood       Date:  2003-06-12       Impact factor: 22.113

Review 10.  Ironing out Ferroportin.

Authors:  Hal Drakesmith; Elizabeta Nemeth; Tomas Ganz
Journal:  Cell Metab       Date:  2015-10-01       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.